FDA.reportPublic FDA data

Trileptal 300 MG in 5 mL Oral Suspension

RxCUI
351992
RxNorm name
Trileptal 300 MG in 5 mL Oral Suspension
Display name
Trileptal 300 MG in 5 mL Oral Suspension
Full name
Trileptal 300 MG in 5 mL Oral Suspension
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:38:57

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
TrileptalOXCARBAZEPINENovartis Pharmaceuticals Corporation4c5c86c8-ab7f-4fcf-bc1b-5a0b1fd0691b2025-12-16Warnings, Adverse reactionsExact identifier
rxcui: 351992

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
4c5c86c8-ab7f-4fcf-bc1b-5a0b1fd0691bTrileptal 300 MG in 5 mL Oral Suspension [PSN] · oxcarbazepine 60 MG/ML Oral Suspension [Trileptal] [SBD] · Trileptal 300 MG per 5 ML Oral Suspension [SY] · Trileptal 60 MG/ML Oral Suspension [SY]439These highlights do not include all the information needed to use TRILEPTAL safely and effectively. See full prescribing information for TRILEPTAL. TRILEPTAL ® (oxcarbazepine) film-coated tablets, for oral use TRILEPTAL ® (oxcarbazepine) oral suspension Initial U.S. Approval: 200020251216